Home

Ověřování učit Triviální os overall survival trm Zatajení Výlet Interpretační

Three-year probability of overall survival (OS), disease-free survival... |  Download Scientific Diagram
Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram

Utility of the Treatment-Related Mortality (TRM) score to predict outcomes  of adults with acute myeloid leukemia undergoing allogeneic hematopoietic  cell transplantation | Leukemia
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation | Leukemia

Five-year overall survival (OS) estimates (A) and 2-year cumulative... |  Download Scientific Diagram
Five-year overall survival (OS) estimates (A) and 2-year cumulative... | Download Scientific Diagram

Cancers | Free Full-Text | Predictors of Survival in Atypical Meningiomas
Cancers | Free Full-Text | Predictors of Survival in Atypical Meningiomas

Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell  Transplantation for Follicular Lymphoma - Biology of Blood and Marrow  Transplantation
Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation

Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less  Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR  Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation
Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation

Outcomes by FLT3-ITD and NPM1 status LFS (a), OS (b), TRM (c), and RI... |  Download Scientific Diagram
Outcomes by FLT3-ITD and NPM1 status LFS (a), OS (b), TRM (c), and RI... | Download Scientific Diagram

Kaplan-Meier curves for overall survival (OS), thalassemia-free... |  Download Scientific Diagram
Kaplan-Meier curves for overall survival (OS), thalassemia-free... | Download Scientific Diagram

A, Overall survival (OS) in patients who received 10‐day decitabine... |  Download Scientific Diagram
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III  NSCLC—an Update From the PACIFIC Trial - ScienceDirect
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial - ScienceDirect

A, Overall survival (OS) in patients who received 10‐day decitabine... |  Download Scientific Diagram
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram

Improved Treatment-Related Mortality and Overall Survival of Patients with  Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow  Transplantation
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation

Overall survival (OS) in elderly AML patients a OS according to period;...  | Download Scientific Diagram
Overall survival (OS) in elderly AML patients a OS according to period;... | Download Scientific Diagram

Overall survival (OS) and relative survival by treatment intensity and... |  Download Scientific Diagram
Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram

Cumulative incidence of cGVHD, transplant-related mortality (TRM),... |  Download Scientific Diagram
Cumulative incidence of cGVHD, transplant-related mortality (TRM),... | Download Scientific Diagram

TRM, Relapse/Progression (1a), Progression Free and Overall Survival... |  Download Scientific Diagram
TRM, Relapse/Progression (1a), Progression Free and Overall Survival... | Download Scientific Diagram

Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus  Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand  1–Selected NSCLC - ScienceDirect
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect

Relapse-free survival (RFS) and overall survival (OS). Kaplan-Meier... |  Download Scientific Diagram
Relapse-free survival (RFS) and overall survival (OS). Kaplan-Meier... | Download Scientific Diagram

Very Young Children Who Undergo Hematopoietic Cell Transplantation at  Weight Extremes Have Inferior Overall Survival and Increased Transplant  Related Morality - Biology of Blood and Marrow Transplantation
Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation

Overall survival (OS) amongst patients with AL amyloidosis undergoing... |  Download Scientific Diagram
Overall survival (OS) amongst patients with AL amyloidosis undergoing... | Download Scientific Diagram

Clinical impact of the loss of chromosome 7q on outcomes of patients with  myelodysplastic syndromes treated with allogeneic hematopoietic stem cell  transplantation | Bone Marrow Transplantation
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation

Osimertinib versus platinum–pemetrexed for patients with EGFR T790M  advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor:  AURA3 overall survival analysis - Annals of Oncology
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology

OS, EFS, Relapse and NRM a Overall Survival (Kaplan-Meïer curves) for... |  Download Scientific Diagram
OS, EFS, Relapse and NRM a Overall Survival (Kaplan-Meïer curves) for... | Download Scientific Diagram

Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and  Carboplatin With or Without Pembrolizumab as First-Line Therapy for  Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology

Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... |  Download Scientific Diagram
Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram

Overall survival and progression-free survival based on high-dose... |  Download Scientific Diagram
Overall survival and progression-free survival based on high-dose... | Download Scientific Diagram